MedPath

Physiological Responses to Exercise Tests in Primary Ciliary Dyskinesia Compared With Healthy Individuals

Completed
Conditions
Primary Ciliary Dyskinesia
Interventions
Other: No intervention
Registration Number
NCT05712798
Lead Sponsor
Hacettepe University
Brief Summary

The individuals with primary ciliary dyskinesia (PCD) have lower aerobic fitness and anaerobic performance than healthy individuals. Cardiopulmonary exercise test (CPET) provides an integrated assessment of integrative exercise responses involving the pulmonary, cardiovascular, hematopoietic, neuropsychological, and skeletal muscle systems that are not adequately reflected by measurement of the function of organ systems. Maximum oxygen consumption is measured by performing gas exchange analysis with CPET, offering an objective measure of cardiorespiratory fitness. The six-minute walk test (6MWT) and the shuttle walk test (SWT) are field tests that produce oxygen consumption results similar to those during CPET. There is a need to determine the physiological responses to CPET, SWT and 6MWT in individuals with PCD. Additionally, the physiological responses of individuals with PCD to different exercise tests will be compared with the responses of healthy individuals. Low aerobic capacity in individuals with PCD may affect the physical, emotional, and social lives of individuals. This influence may cause a decrease in the quality of life of individuals with PCD. The relationship between exercise capacity and quality of life in individuals with PSD will be investigated with this study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Having been diagnosed with PCD in the Pediatrics Department, Pediatric Chest Diseases Unit of Hacettepe University Faculty of Medicine and being routinely referred to Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit for physiotherapy applications and pulmonary rehabilitation program,
  • Being clinically stable,
  • Being between 8-18 years old,
  • Having a forced expiratory volume in the first second (FEV1) ≥ 40%,

The healthy group will be composed of individuals who do not have any known disease and volunteer to participate in the study. For healthy individuals, volunteers from acquaintances and/or relatives of the researchers will be included in the study.

Exclusion Criteria
  • Having unstable clinical condition
  • Having severe neuromuscular and musculoskeletal problems,
  • Having any congenital heart diseases other than situs inversus,
  • Unable to cooperate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
The children with primary ciliary dyskinesiaNo interventionThe children with primary ciliary dyskinesia
Healthy controlsNo interventionHealthy children
Primary Outcome Measures
NameTimeMethod
Maximal oxygen uptakeup to 3 weeks

Maximal oxygen uptake will be determined using cardiopulmonary exercise test.

6 minute walk test distanceup to 3 weeks

6 minute walk test distance will be determined using 6 minute walk test

Quality of life score1st day

Quality of life score will be determined using multidimensional measure to assess health-related quality of life in primary ciliary dyskinesia (QoL-PCD).

Shuttle walk test distanceup to 3 weeks

Shuttle walk test distance will be determined using shuttle walk test

Secondary Outcome Measures
NameTimeMethod
Pulmonary function test - forced vital capacity1st day

Pulmonary function test using a spirometer will be performed. Forced vital capacity will be recorded.

Pulmonary function test - Forced expiratory volume in one second1st day

Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second will be recorded.

Pulmonary function test - Peak expiratory flow1st day

Pulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded.

Maximal expiratory pressure1st day

Maximal expiratory pressure will be measured using a mouthpiece device.

Maximal inspiratory pressure1st day

Maximal inspiratory pressure will be measured using a mouthpiece device.

Pulmonary function test - Forced mid-expiratory flow (FEF25-75)1stday

Pulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded.

Trial Locations

Locations (1)

Hacettepe University Faculty of Physical Therapy and Rehabilitation

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath